TOG Topics List

This post is about the TOG topics list with links starting from 2012 till April 2025. The download links to the 'free access' articles have been provided. All you have to do is to click the specific topic and the article will be open in a new window.

My purpose in sharing it with you all is to give an idea about 'organising your study material' in a way to save your precious time. This is a practical answer to a  frequently asked question, “What are the TOG articles in a specific year?”

You need a subscription to access the articles for which no links are given. After a specific time, the article becomes free to access. The list will make sure that you get all the important articles. You must add to this list whenever a new TOG issue is published.

All the best.

Dr Rubab Khalid

TOG LIST

2025

APRIL 2025

• Non-trophoblastic tumours of the placenta: pathophysiology, diagnosis and management
• Preventing and reducing the morbidity and mortality of preterm birth in singleton pregnancies
• Hirsutism: a guide for the obstetrician and gynaecologist
• Ovarian hyperstimulation syndrome – risk reduction strategies
• Abdominal wall catheters for postoperative analgesia in patients undergoing open gynaecological procedures

JANUARY 2025

• Placenta accreta spectrum: imaging and diagnosis
• Review of global inequalities in management of gynaecological cancer
• COVID-19 in pregnancy
• Perinatal mental health: an overview of pathology,services and the law
• Enhanced recovery revisited
• Performance anxiety: implications for obstetricians and gynaecologists

2024

OCTOBER 2024

• Urethral Carnucles
• Endometriosis as a risk factor for ovarian cancer
• Surgical techniques for ovarian endometriosis
• AI in medicine

JULY 2024

• Use of psychotropic medication in perinatal period
• Gynaecological pathology and ART
• Premature ovarian insufficiency

APRIL 2024

• Sarcoidosis in Pregnancy
• Hyperthermic intraperitoneal chemotherapy (HIPEC) in the management of ovarian cancer
• Heavy menstrual bleeding in adolescence: who to investigate and how to manage it
• What's new in guidance? Urinary incontinence and pelvic organ prolapse (NICE guideline NG 123)
• A proactive safety approach to delivering safer care in obstetrics and gynaecology

JANUARY 2024

• Telemedicine and remote training: the impact on obstetrics and gynaecology training
• Endometriosis and subfertility Summary Click Here
• Diagnosis and management of vulval intraepithelial neoplasia
• Cosmetic Gynaecology

2023

OCTOBER 2023

• Extracorporeal membrane oxygenation (ECMO) in pregnant and postpartum women
• A focus on progestogens in hormone replacement therapy
• Vulval disorders in paediatric and adolescent patients and their management
• Information sharing and communication in management of large for gestational age babies in non-diabetic mothers

JULY 2023

• Quantification of blood loss in obstetric haemorrhage: implications on intervention and transfusion
• Tuberculosis in Pregnancy Summary Click Here
• Gastrointestinal congenital anomalies requiring surgery: diagnosis, counselling, and management
• Hyperlipidaemia and severe hypertriglyceridaemia in pregnancy
• Sentinel lymph node mapping in the modern management of gynaecological malignancy
• Recent trends in molecular testing and maintenance targeted therapies in ovarian cancer
• Menopause and mental health

APRIL 2023

• Acute coronary syndromes in Pregnancy
• Non-immune hydrops fetalis
• Prenatal genomic testing for ultrasound-detected fetal structural anomalies
• The clinical applications of interventional radiological techniques in obstetrics and gynaecology
• Consenting, competence and confidentiality in paediatric adolescent gynaecology
• Postpartum perineal wound dehiscence

JANUARY 2023

• Management of term breech presentation
• Valvular heart disease in pregnancy
• Pitfalls of prenatal diagnosis associated with Mosaicism 
• Premenstrual disorders
• HPV-independent cervical cancer and its precursor lesions
• Thromboprophylaxis is gynaecology 
• Management of Bartholin’s cyst and abscess

2022

MRCOG Part 2 Revision Course | July 2025

www.rubabk4courses.com

Enrol Now for MRCOG Part 2 Revision Course | July 2025!!

Features

• Twice Weekly Interactive Live Sessions 2-3 hours duration conducted using Zoom software
• Session Recordings accessible until the exam day
• Total LIVE Sessions: 12-15
• Important Exam Topics covered module-wise
• Free Mock Test 1200+ SBAs & EMQs to practice
• Starting 11 March 2025
• Session Timings 19:30 to 22:30 PKT
• Tips and Tricks to Tackle SBAs and EMQs
• Focus on concepts and critical thinking — deal with ANY exam question
• Supervised WhatsApp Study Group to discuss and clarify queries, SBAs, EMQs

 

To Register Visit the Course Website

https://www.rubabk4courses.com/courses/ 

Payment Options:

• Credit/Debit Card payment is available
• Direct Bank Transfer in PKR (For Pakistani Candidates ONLY)

DIRECT BANK TRANSFER

Account Title: RUBABK4 COURSES (SMC-PVT) LTD

IBAN: PK33 HABB 0015897918851803

Bank: Habib Bank Limited (HBL)

Swift Code: HABBPKKA589

NTN: 826315-7 

Address: Peco Road Centre, Lahore, Pakistan

 *After the payment, please share the receipt on

WhatsApp: +92 316 4371557

Email: rubabk4courses@gmail.com 

LIVE Sessions Outline

No.	Module	Topics to Cover
1	Early Pregnancy Care	GTG 21 Ectopic Pregnancy  NICE Miscarriage  GTG 38 Gestational Trophoblastic Disease  GTG 69 Hyperemesis Gravidarum GTG 5 OHSS
2	Urogynaecology	NICE Urinary Incontinence  Urodynamics Studies  GTG 46 Post-hysterectomy Vaginal Vault Prolapse GTG 70 Bladder Pain Syndrome

GTG 55 | Late Intrauterine Fetal Death & Stillbirth

This post highlights the key updates from the November 2024 revision of GTG 55: Late Intrauterine Fetal Death (IUFD) and Stillbirth. These updates bring critical changes that are not only pivotal for clinical practice but also for anyone preparing for the MRCOG exams.

GTGs remain an invaluable resource for MRCOG preparation, and understanding these updates in depth is key to staying ahead. I’ve summarized the main points in this post, making it a concise and accessible guide for busy professionals.

I hope you find this post informative and helpful. Your feedback and suggestions to enhance future posts are always appreciated—feel free to share your thoughts in the comments!

To download Pdfs: All GTGs Links

All GTG Summaries: RK4 Courses

RK4 Courses

Definitions

Late Intrauterine Fetal Death

• Babies with no signs of life in utero after 24⁺⁰ completed wks of pregnancy

Stillbirth

• Baby delivered with no signs of life known to have died after 24⁺⁰ completed wks of pregnancy

Background & Epidemiology

• Late IUFD 1 in 250
• Sudden Infant death 1 per 10000 live births
• According to MBRRACE-UK National Perinatal Mortality Surveillance Report
• Extended perinatal mortality reduced by 18% ^{over 6 years} 
• Stillbirth reduced by just over 20%
• Stillbirths in 2021  3.54 per 1000 total births in UK
• Babies of women living in the most deprived areas – twice as likely to be stillborn
• Black & Black British ethnicity - twice stillbirth rates

Diagnosis of IUFD

• Avoid auscultation for fetal heart by Pinard stethoscope or Doppler USG or CTG 

Real-time USG

• Essential for accurate dx – allows direct visualization of fetal heart
• Offer discussion of USG findings with parents – for anticipated appearance of baby at birth & explain time of fetal death
• Sensitivity to diagnose occult placental abruption 15%
• Patient may have passive fetal movements; must counsel & may offer repeat scan 

Communicating the diagnosis 

• Provide written information
• Use clear language
• Avoid jargons
• Use professional interpreter
• Give time to absorb the news
• Support maternal/paternal choices

Labour & Birth

• Informed decision b/w parents & experienced obstetrician
• Consider woman’s choice, medical conditions & previous intrapartum history

Suitable Birth facilities  

• Depend on individual circumstances
• Special labour wards room with special focus on emotional & practical needs
• Care to be given by an experienced midwife + obstetrician

Options for birth   SVD  IOL ^{immediate/delayed}  CS  Expectant

Vaginal birth   

• Recommended for most women
• VD Emotionally distressing in IUFD 47% ^{vs 7% in live births}
• VD can occur within 24 hrs of IOL in ~90%
• ↑ shoulder dystocia, clinical chorioamniotis, PPH & retained placenta
• 4-fold ↑ in severe maternal morbidity

Caesarean Section  

• needed for some 
• ↓ perineal trauma, urinary incontinence & POP 
• ↑ surgical morbidity, ↑ risks for fertility & ↑ risks in future pregnancies

Timing of Birth

• No optimal interval to birth

Physically well + Intact membranes + No lab evidence of DIC

• can delay labour for 48 hours   
• if longer then must have testing for DIC
• 10% risk of DIC within 4 weeks
• Interval b/w dx & delivery can ↑ anxiety & DIC

Prolonged Expectant mx

• may ↓ diagnostic value of postmortem
• ≥24 hrs interval from dx to start of labour associated with ↑ risk of moderately severe anxiety or worse OR 4.8

Pool birth   

• Can be offered Late IUFD not a contraindication

Induction of labour

• First-line intervention   Combination of Mifepristone & Misoprostol

FIGO Misoprostol Dosing Regimen 2023
A single 200 mg Mifepristone followed by:
24+0 – 24+6 wks	400 μg misoprostol every 3 hrs
25+0 – 27+6 wks	200 μg misoprostol every 4 hrs
From 28+0 wks	25–50 μg vaginal misoprostol every 4 hrs or 50–100 μg oral misoprostol every 2 hrs

Mifepristone Use

Mifepristone + Misoprostol  vs misoprostol alone

• Significantly shorter time to birth 6.72 ±3.34 hrs vs 11.81 ±6.33 hrs
• Mean induction-birth interval shorter 9.8 vs 16.3
• Less # of misoprostol doses needed & earlier onset of labour
• Mifepristone prior to misoprostol ↑ chance of vaginal birth from 71% to 92%

Misoprostol  

• off-label in UK for IOL in stillbirth
• Vaginal as effective as oral with fewer side effects
• Both routes up to 100% effective in achieving birth at 48 hrs
• Preferable to prostaglandin E2 with equivalent safety, lower cost & lower doses

IOL with previous CS